Looks like you clickedhttps://www.onclive.com/insights/cll-treatment-updates/evaluating-pharmacologic-agents-in-relapsed-refractory-cll?eKey=bGVua2Vja0Bjb21jYXN0Lm5ldA==&utm_medium=email&utm_campaign=ONCSS%20CLL%20CC%20eNews%20Imbruvica%20Janssen%20%2010-16-18&utm_content=ONCSS%20CLL%20CC%20eNews%20Imbruvica%20Janssen%20%2010-16-18+CID_58a96f7ae932f39fd9659acff83f91c4&utm_source=CM%20ONCLIVE&utm_term=Evaluating%20Pharmacologic%20Agents%20in%20RelapsedRefractory%20CLL
If you do not want to visit that page, you can close this browser tab.
